FIELD: medicine, pharmacology. SUBSTANCE: invention proposes the use of lomir (isradipine) as an agent for treatment of patients with localized scleroderma. EFFECT: enhanced effectiveness of treatment. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF PATIENT WITH REITER'S DISEASE | 1994 |
|
RU2085210C1 |
| METHOD FOR TREATING LOCALIZED SCLERODERMA | 2004 |
|
RU2264815C2 |
| METHOD FOR TREATMENT OF SKIN MANIFESTATIONS OF A SCLERODERMA | 2016 |
|
RU2657812C2 |
| METHOD OF TREATING PATIENTS WITH LOCALISED SCLERODERMA | 2014 |
|
RU2564905C1 |
| METHOD FOR TREATING THE CASES OF CIRCUMSCRIBED SCLERODERMA | 1999 |
|
RU2147896C1 |
| METHOD FOR DETERMINING EFFICIENCY OF LIMITED SCLERODERMATITIS THERAPY | 2007 |
|
RU2331361C1 |
| METHOD OF TREATING CHRONIC INFLAMMATORY DERMATOSES IN CHILDREN | 1998 |
|
RU2175244C2 |
| METHOD OF COMBINATION THERAPY OF CIRCUMSCRIBED SCLERODERMIA WITH APPLYING LOCAL TRANSDERMAL ENZYMIC ELECTROSTATIC EXPOSURE | 2009 |
|
RU2403921C1 |
| METHOD OF MORPHEA GUTTATA TREATMENT | 2019 |
|
RU2716488C1 |
| METHOD OF TREATING MORPHEA | 2010 |
|
RU2424008C1 |
